Magdalena Sierra

661 total citations
14 papers, 236 citations indexed

About

Magdalena Sierra is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Magdalena Sierra has authored 14 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Magdalena Sierra's work include Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Magdalena Sierra is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Magdalena Sierra collaborates with scholars based in Spain, Germany and Chile. Magdalena Sierra's co-authors include Jesús F. San Miguel, Ramón García‐Sánz, Marcos González, Carlos López, Jesús María Hernández‐Rivas, José J. Pérez, Emilia Pardal, Alfonso García de Coca, Norma C. Gutiérrez and José‐Ángel Hernández‐Rivas and has published in prestigious journals such as Blood, International Journal of Cancer and PLoS Computational Biology.

In The Last Decade

Magdalena Sierra

11 papers receiving 227 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Magdalena Sierra Spain	7	135	126	70	64	23	14	236
Louis Williams United States	9	110 0.8×	84 0.7×	67 1.0×	22 0.3×	12 0.5×	44	185
Naoki Shingai Japan	10	174 1.3×	46 0.4×	34 0.5×	36 0.6×	15 0.7×	29	229
Ma Teresa Cibeira Spain	8	272 2.0×	224 1.8×	153 2.2×	51 0.8×	13 0.6×	13	306
Joel Hetzer United States	8	292 2.2×	143 1.1×	28 0.4×	69 1.1×	9 0.4×	17	326
María-Victoria Mateos United States	6	234 1.7×	177 1.4×	161 2.3×	38 0.6×	10 0.4×	13	281
Barbara Pocali Italy	10	158 1.2×	37 0.3×	59 0.8×	58 0.9×	37 1.6×	14	222
Maria Carmen Martorelli Italy	8	153 1.1×	64 0.5×	82 1.2×	74 1.2×	15 0.7×	17	219
Katarina Uttervall Sweden	8	202 1.5×	122 1.0×	121 1.7×	31 0.5×	18 0.8×	25	229
Véronique Harrivel France	8	115 0.9×	39 0.3×	34 0.5×	59 0.9×	14 0.6×	17	170
Esperanza Lavilla Spain	8	82 0.6×	65 0.5×	100 1.4×	36 0.6×	49 2.1×	12	200

Countries citing papers authored by Magdalena Sierra

Since Specialization

Citations

This map shows the geographic impact of Magdalena Sierra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Sierra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Sierra more than expected).

Fields of papers citing papers by Magdalena Sierra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdalena Sierra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Sierra. The network helps show where Magdalena Sierra may publish in the future.

Co-authorship network of co-authors of Magdalena Sierra

This figure shows the co-authorship network connecting the top 25 collaborators of Magdalena Sierra. A scholar is included among the top collaborators of Magdalena Sierra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdalena Sierra. Magdalena Sierra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Arias, Raquel De Paz, Ángel Ramírez Páyer, Magdalena Sierra, et al.. (2024). Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC study. Annals of Hematology. 103(10). 4045–4055. 1 indexed citations

Sierra, Magdalena, et al.. (2024). Comparing AI versus optimization workflows for simulation-based inference of spatial-stochastic systems. Machine Learning Science and Technology. 6(1). 10502–10502. 1 indexed citations

Sierra, Magdalena, et al.. (2024). AI-powered simulation-based inference of a genuinely spatial-stochastic gene regulation model of early mouse embryogenesis. PLoS Computational Biology. 20(11). e1012473–e1012473. 4 indexed citations

Hernández‐Sánchez, María, Teresa González, Miguel Quijada‐Álamo, et al.. (2020). Chronic lymphocytic leukemia patients withIGHtranslocations are characterized by a distinct genetic landscape with prognostic implications. International Journal of Cancer. 147(10). 2780–2792. 19 indexed citations

Vázquez, Lourdes, Fernando Ramos, Beatriz Cuevas, et al.. (2015). Incidence of haematological neoplasms in Castilla y León, Spain. Medicina Clínica (English Edition). 144(11). 491–500.

Vázquez, Lourdes, Fernando Ramos, Beatriz Cuevas, et al.. (2014). Estudio de incidencia de las neoplasias hematopoyéticas en Castilla y León. Medicina Clínica. 144(11). 491–500.

González‐Porras, José Ramón, Fernando Escalante, Emilia Pardal, et al.. (2013). Safety and efficacy of splenectomy in over 65‐yrs‐old patients with immune thrombocytopenia. European Journal Of Haematology. 91(3). 236–241. 47 indexed citations

Sierra, Magdalena, et al.. (2013). LAS DINÁMICAS TERRITORIALES NATURALES COMO ARTICULADORES DEL ESPACIO E IMAGEN URBANA: COYHAIQUE Y COCHRANE XI REGIÓN DE AYSÉN. 11–14.

Paiva, Bruno, María‐Belén Vídriales, José J. Pérez, et al.. (2011). The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis. Blood. 117(13). 3613–3616. 46 indexed citations

10.

Sarasquete, María Eugenia, Ramón García‐Sánz, Carmen Chillón, et al.. (2008). Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma. British Journal of Haematology. 141(2). 212–215. 28 indexed citations

11.

Sierra, Magdalena, Álvaro Alonso, María D. Odero, et al.. (2006). Geographic differences in the incidence of cytogenetic abnormalities of acute myelogenous leukemia (AML) in Spain. Leukemia Research. 30(8). 943–948. 17 indexed citations

12.

Sierra, Magdalena, Jesús María Hernández‐Rivas, Jesús María Hernández‐Rivas, et al.. (2005). Hematological, immunophenotypic, and cytogenetic characteristics of acute myeloblastic leukemia with trisomy 11. Cancer Genetics and Cytogenetics. 160(1). 68–72. 6 indexed citations

13.

García‐Sánz, Ramón, et al.. (2002). The combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is feasible and can be an option for relapsed/refractory multiple myeloma. The Hematology Journal. 3(1). 43–48. 47 indexed citations

14.

Pérez-Simón, Josè Antonio, et al.. (2000). Intra-muscular vidarabine therapy for polyomavirus-associated hemorrhagic cystitis following allogeneic hemopoietic stem cell transplantation. Bone Marrow Transplantation. 26(11). 1229–1230. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact